| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PLoSO...623596H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0023596 |
| P8608 | Fatcat ID | release_wjuhfov76neqrizj2u2mmhvaxa |
| P932 | PMC publication ID | 3157391 |
| P698 | PubMed publication ID | 21858179 |
| P5875 | ResearchGate publication ID | 51586987 |
| P50 | author | Peter Schmidt | Q57631064 |
| Johannes-Peter Stasch | Q66360867 | ||
| P2093 | author name string | Harald H H W Schmidt | |
| Carsten Hoffmann | |||
| Linda S Hoffmann | |||
| Yvonne Keim | |||
| P2860 | cites work | FlAsH-based live-cell fluorescent imaging of synthetic peptides expressed in Arabidopsis and tobacco | Q57375788 |
| Design of an Artificial Light-Harvesting Unit by Protein Engineering: Cytochrome b562–Green Fluorescent Protein Chimera | Q58187999 | ||
| A Förster-resonance-energy transfer-based method for fluorescence detection of the protein redox state | Q60709705 | ||
| Conformational dynamics and molecular interaction reactions of recombinant cytochrome p450scc (CYP11A1) detected by fluorescence energy transfer | Q73169661 | ||
| Identification of residues crucially involved in soluble guanylate cyclase activation | Q79871327 | ||
| Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation | Q39847509 | ||
| Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes. | Q39902082 | ||
| A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway. | Q40446987 | ||
| Heat shock protein 90 regulates stabilization rather than activation of soluble guanylate cyclase | Q42030989 | ||
| Inhibition of soluble guanylate cyclase by ODQ. | Q42055822 | ||
| Role of conformational changes in the heme-dependent regulation of human soluble guanylate cyclase | Q43823331 | ||
| Metabolites of orally active NO-independent pyrazolopyridine stimulators of soluble guanylate cyclase | Q43950505 | ||
| New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications | Q44001816 | ||
| Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production | Q44258988 | ||
| Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase | Q44626758 | ||
| A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells | Q46396170 | ||
| Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure | Q48260348 | ||
| Engineering, expression, purification, and physicochemical characterization of a chimeric protein, full-length cytochrome b(5)--green fluorescence protein (HMWb5--EGFP). | Q50696513 | ||
| Revealing two-state protein-protein interactions of calmodulin by single-molecule spectroscopy. | Q50726225 | ||
| Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo. | Q51795151 | ||
| NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential | Q24656131 | ||
| NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism | Q27641107 | ||
| Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase | Q27661554 | ||
| Specific covalent labeling of recombinant protein molecules inside live cells | Q28276029 | ||
| Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats | Q28362046 | ||
| Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase | Q28379365 | ||
| Golgi twins in late mitosis revealed by genetically encoded tags for live cell imaging and correlated electron microscopy | Q30478267 | ||
| Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats | Q33178899 | ||
| Allosteric transitions in cytochrome P450eryF explored with pressure-perturbation spectroscopy, lifetime FRET, and a novel fluorescent substrate, Fluorol-7GA. | Q33373477 | ||
| Guanylyl cyclases and signaling by cyclic GMP. | Q33917038 | ||
| NO-independent, haem-dependent soluble guanylate cyclase stimulators | Q34906036 | ||
| Fluorescent labeling of tetracysteine-tagged proteins in intact cells | Q34913250 | ||
| Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels | Q35009484 | ||
| Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome | Q35009508 | ||
| Creating new fluorescent probes for cell biology. | Q35014035 | ||
| NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle | Q35044464 | ||
| Oxidation and loss of heme in soluble guanylyl cyclase from Manduca sexta | Q35083181 | ||
| Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase | Q35124292 | ||
| Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral | Q35361856 | ||
| Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. | Q35582722 | ||
| Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier? | Q36927106 | ||
| Surveying polypeptide and protein domain conformation and association with FlAsH and ReAsH. | Q37185091 | ||
| Novel techniques for real-time monitoring of cGMP in living cells. | Q37352778 | ||
| NO- and haem-independent soluble guanylate cyclase activators | Q37352787 | ||
| Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis | Q37692538 | ||
| Probing the presence of the ligand-binding haem in cellular nitric oxide receptors | Q39504233 | ||
| Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation | Q39845753 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e23596 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells | |
| P478 | volume | 6 |
| Q36424922 | Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice |
| Q58696712 | Comparative Studies of the Dynamics Effects of BAY60-2770 and BAY58-2667 Binding with Human and Bacterial H-NOX Domains |
| Q27021649 | Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS |
| Q41770411 | Insight into the rescue of oxidized soluble guanylate cyclase by the activator cinaciguat |
| Q27677544 | Insights into BAY 60-2770 Activation and S -Nitrosylation-Dependent Desensitization of Soluble Guanylyl Cyclase via Crystal Structures of Homologous Nostoc H-NOX Domain Complexes |
| Q41879996 | NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size |
| Q38191314 | Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation. |
| Q37660997 | Probing the Molecular Mechanism of Human Soluble Guanylate Cyclase Activation by NO in vitro and in vivo |
| Q38130465 | The chemistry and biology of soluble guanylate cyclase stimulators and activators |
Search more.